黑料网

ISSN: 2475-3173

Cervical Cancer: 黑料网
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Hypothesis   
  • Cervical Cancer, Vol 9(1): 193

Genetic Testing in Oncology: Implications for Cancer Treatment

Diane Nijjar*
Department of Public Health and Informatics, Aureus University School of Medicine, Aruba
*Corresponding Author : Diane Nijjar, Department of Public Health and Informatics, Aureus University School of Medicine, Aruba, Email: Diane.nijjar@gmail.com

Received Date: Feb 01, 2024 / Published Date: Feb 29, 2024

Abstract

Genetic testing has emerged as a pivotal tool in oncology, facilitating personalized treatment approaches by identifying specific genetic mutations that drive cancer development and progression. This article explores the implications of genetic testing in oncology, focusing on its role in guiding targeted therapies, predicting treatment responses, and shaping personalized treatment strategies. Challenges in interpretation, ethical considerations, and future directions in the field are also discussed.

Citation: Diane N (2024) Genetic Testing in Oncology: Implications for CancerTreatment. Cervical Cancer, 9: 193.

Copyright: © 2024 Diane N. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top